22 related articles for article (PubMed ID: 8050579)
1. Shark class II invariant chain reveals ancient conserved relationships with cathepsins and MHC class II.
Criscitiello MF; Ohta Y; Graham MD; Eubanks JO; Chen PL; Flajnik MF
Dev Comp Immunol; 2012 Mar; 36(3):521-33. PubMed ID: 21996610
[TBL] [Abstract][Full Text] [Related]
2. Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.
Frauwirth K; Shastri N
Immunology; 2001 Apr; 102(4):405-15. PubMed ID: 11328374
[TBL] [Abstract][Full Text] [Related]
3. Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells.
Pierre P; Shachar I; Matza D; Gatti E; Flavell RA; Mellman I
J Exp Med; 2000 Mar; 191(6):1057-62. PubMed ID: 10727467
[TBL] [Abstract][Full Text] [Related]
4. Friends and relations of the cystatin superfamily--new members and their evolution.
Brown WM; Dziegielewska KM
Protein Sci; 1997 Jan; 6(1):5-12. PubMed ID: 9007972
[TBL] [Abstract][Full Text] [Related]
5. Physiological functions of endosomal proteolysis.
Berg T; Gjøen T; Bakke O
Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):313-26. PubMed ID: 7733863
[No Abstract] [Full Text] [Related]
6. The p41 fragment story.
Turk D; Guncar G; Turk V
IUBMB Life; 1999 Jul; 48(1):7-12. PubMed ID: 10791909
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
Guncar G; Pungercic G; Klemencic I; Turk V; Turk D
EMBO J; 1999 Feb; 18(4):793-803. PubMed ID: 10022822
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
9. Potential sites for processing of the human invariant chain by cathepsins D and E.
Kageyama T; Yonezawa S; Ichinose M; Miki K; Moriyama A
Biochem Biophys Res Commun; 1996 Jun; 223(3):549-53. PubMed ID: 8687433
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and regulation of antigen processing by cathepsin B.
Katunuma N; Matsunaga Y; Saibara T
Adv Enzyme Regul; 1994; 34():145-58. PubMed ID: 7942272
[TBL] [Abstract][Full Text] [Related]
11. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
[TBL] [Abstract][Full Text] [Related]
12. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family.
Katunuma N; Kakegawa H; Matsunaga Y; Saibara T
FEBS Lett; 1994 Aug; 349(2):265-9. PubMed ID: 8050579
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]